Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Financial Flexibility Index
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥304.82 Million (operating CF CN¥283.54 Million minus capex CN¥21.27 Million) represents 0% of total liabilities (CN¥4.51 Billion). Check Heilongjiang ZBD Pharmaceutical Co Ltd (603567) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Heilongjiang ZBD Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Heilongjiang ZBD Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Heilongjiang ZBD Pharmaceutical Co Ltd (603567) cash flow conversion.
Annual Financial Flexibility Index for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Heilongjiang ZBD Pharmaceutical Co Ltd. Explore 603567 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | CN¥390.62 Million | CN¥322.10 Million | CN¥4.36 Billion | ▲ +12.2% |
| 2024 | 0.08x | CN¥353.46 Million | CN¥164.31 Million | CN¥4.42 Billion | ▲ +197.5% |
| 2023 | -0.08x | CN¥-362.76 Million | CN¥-457.90 Million | CN¥4.43 Billion | ▼ -583.4% |
| 2022 | 0.02x | CN¥77.48 Million | CN¥-326.79 Million | CN¥4.57 Billion | ▲ +414.2% |
| 2021 | 0.00x | CN¥14.69 Million | CN¥-433.94 Million | CN¥4.45 Billion | ▼ -98.5% |
| 2020 | 0.22x | CN¥1.02 Billion | CN¥155.18 Million | CN¥4.73 Billion | ▲ +104.0% |
| 2019 | 0.11x | CN¥399.71 Million | CN¥220.92 Million | CN¥3.77 Billion | ▼ -56.9% |
| 2018 | 0.25x | CN¥786.99 Million | CN¥367.40 Million | CN¥3.20 Billion | ▼ -59.6% |
| 2017 | 0.61x | CN¥1.35 Billion | CN¥853.19 Million | CN¥2.21 Billion | ▲ +285.0% |
| 2016 | 0.16x | CN¥334.57 Million | CN¥15.83 Million | CN¥2.11 Billion | ▲ +222.8% |
| 2015 | -0.13x | CN¥-253.93 Million | CN¥-323.90 Million | CN¥1.97 Billion | ▼ -139.6% |
| 2014 | 0.33x | CN¥466.18 Million | CN¥386.32 Million | CN¥1.43 Billion | ▲ +42.6% |
| 2013 | 0.23x | CN¥343.41 Million | CN¥174.68 Million | CN¥1.50 Billion | ▼ -52.4% |
| 2012 | 0.48x | CN¥387.34 Million | CN¥154.25 Million | CN¥808.30 Million | ▲ +1.3% |
| 2011 | 0.47x | CN¥244.49 Million | CN¥104.71 Million | CN¥516.70 Million | — |